Moderna Covid vaccine sales plunge by two-thirds in 2023, but meet company’s $6 billion forecast

[ad_1] Nikos Pekiaridis | Lightrocket | Getty Images Moderna on Monday said its Covid vaccine sales plunged by about two-thirds in 2023 to $6.7 billion, as fewer people rolled up…

Moderna stock pops after Oppenheimer says Covid shot maker could launch more products over next two years

[ad_1] Artur Widak | Nurphoto | Getty Images Shares of Moderna closed more than 13% higher on Tuesday after Oppenheimer upgraded the stock to “outperform,” saying the Covid vaccine maker…

Here are the big health sector themes to watch next year

[ad_1] An employee works on the production line of pharmaceutical company Zentiva in Prague, Czech Republic, May 6, 2021. David W. Cerny | Reuters The health-care sector has wiped out…

Moderna, Merck vaccine with Keytruda cuts risk of deadly skin cancer returning in half, data says

[ad_1] An exterior view of Moderna’s clinical manufacturing facility.  David L. Ryan | Boston Globe | Getty Images Moderna and Merck‘s experimental cancer vaccine, when used in combination with Merck’s…

Pfizer shares fall as 2024 revenue and profit forecast disappoints

[ad_1] Shares of Pfizer fell Wednesday after the drugmaker forecast 2024 revenue and profit below Wall Street’s expectations, as it sees weak demand for its once-blockbuster Covid products.  Pfizer also…

Covid vaccine rates in the U.S. are slumping — and it will be a challenge to boost them

[ad_1] A sign advertises Covid vaccine shots at a Walgreens Pharmacy in Somerville, Massachusetts, on Aug. 14, 2023. Brian Snyder | Reuters Three years into the Covid-19 pandemic, few Americans…

Moderna stock falls as sinking Covid vaccine demand drives steep loss

[ad_1] Moderna on Thursday posted a steep loss for the third quarter as it recorded a large write-down due to unused doses of its Covid vaccine, its only marketable product,…

Pfizer swings to quarterly loss due to Paxlovid, Covid vaccine write-offs

[ad_1] CFOTO | Future Publishing | Getty Images Pfizer on Tuesday reported a narrower than expected adjusted loss for the third quarter as the drugmaker recorded charges largely related to…

Pfizer’s combination Covid, flu vaccine will move to final-stage trial after positive data

[ad_1] CFOTO | Future Publishing | Getty Images Pfizer on Thursday said its combination vaccine candidates targeting Covid and the flu will move to a final-stage trial in the coming…

Merck results beat expectations on strong Keytruda sales, surprise Covid drug growth

[ad_1] Merck headquarters in Rahway, New Jersey, on Tuesday, April 18, 2023. Christopher Occhicone | Bloomberg | Getty Images Merck on Thursday reported third-quarter revenue and adjusted earnings that topped…